Medicine for treating puerperal fever

A postpartum fever and drug technology, applied in the field of medicine, can solve problems such as poor fever effect

Inactive Publication Date: 2014-06-18
0 Cites 5 Cited by

AI-Extracted Technical Summary

Problems solved by technology

Antibiotics are currently used for treatment, but Wester...
View more


The invention relates to a medicine for treating puerperal fever. The medicine is prepared from the following crude medicines in parts by weight: 12 parts of philydrum lanuginosum, 15 parts of lombardy poplar, 10 parts of calogyne pilosa, 8 parts of cabbage, 6 parts of climbing groundsel herb, 10 parts of dried tangerine or orange peel, 5 parts of selfheal, 8 parts of cortex dictamni, 10 parts of dandelion, 5 parts of thalictrum, 2 parts of cuttlebone, 7 parts of gardeniae, 6 parts of rhizome of Chinese atractylode, 6 parts of folium mori, 7 parts of prepared rhizome of rehmannia, 3 parts of kelp, 2 parts of cimicifugae foetidae, 6 parts of peach kernel, 3 parts of blackend swallowwort root, 8 parts of honeysuckle, 5 parts of sappan wood, 3 parts of inula flower, 3 parts of Chinese mesona herb, 6 parts of root of common peony, 2 parts of selfheal, 7 parts of oriental wormwood, 5 parts of safflower, 7 parts of dark plum, 5 parts of cortex albiziae, 3 parts of sanguisorba officinalis, 3 parts of lycopodium clavatum, 6 parts of schizonepeta, 6 parts of motherwort, 2 parts of agastache rugosus and 3 parts of tangerine peel. The medicine for treating the puerperal fever disclosed by the invention has the characteristics of being reasonable in prescription, concrete in curative effect, safe and convenient, free from toxic and side effect, and low in cost.

Application Domain

AntipyreticAnalgesics +3

Technology Topic

CarthamusDandelion +19


  • Medicine for treating puerperal fever
  • Medicine for treating puerperal fever
  • Medicine for treating puerperal fever


  • Experimental program(1)

Example Embodiment

[0016] Experimental example
[0017] Diagnostic criteria
[0018] According to (Tian Bing. Observation on clinical efficacy of Jiawei Shenghua Decoction in treating postpartum fever [J]. Chinese Community Physician (Medical Profession), 2011, 12(33): 149-150) to formulate diagnostic criteria: persistent fever within 10 days after delivery, or The body temperature above 38°C lasted for 3 days, accompanied by abdominal pain and abnormal changes in the color, quality, quantity, and smell of vaginal secretions. The pathogenic bacteria and the site of infection were identified through routine blood and urine examinations and culture of uterine secretions.
[0019] normal information
[0020] A total of 84 patients with postpartum fever admitted to the Obstetrics and Gynecology Department of our hospital from May 2012 to November 2013 were selected and divided into a treatment group and a control group, with 42 cases in each group. The average age of the treatment group was (24.6±3.8) years old; 26 primiparous women , 16 cases of multipartum women; body temperature 37.7 ℃ -41.1 ℃. The average age of the control group was (24.7±3.2) years old; there were 24 cases of primiparous women and 18 cases of multiparous women; their body temperature ranged from 37.9°C to 40.7°C. Pregnant women in the two groups were all singletons, and their age, parity, gestational age at childbirth, body temperature, etc. were statistically processed, and there was no statistically significant difference (P>0.05), which was comparable.
[0021] The control group took clindamycin hydrochloride capsules (Hunan Kangpu Pharmaceutical Co., Ltd.) orally, twice a day, 0.2 g each time, for 10 days.
[0022] The treatment group was treated with the ointment prepared in the embodiment, once a day, and the left and right temples of the patient were each evenly coated with the ointment of a hose for 10 days.
[0023] Efficacy standard
[0024] According to ([6] State Administration of Traditional Chinese Medicine. Criteria for Diagnosis and Curative Effect of TCM Syndrome [S]. Nanjing: Nanjing University Press, 1994:70). Markedly effective: the clinical symptoms disappear, the body temperature is normal, and the laboratory examination returns to normal; effective: the clinical symptoms are reduced, the body temperature drops, and the laboratory examination takes a turn for the better; invalid: there is no significant change in the clinical symptoms, and even the condition worsens.
[0025] Statistical methods
[0026] SPSS17.0 software was used to process and count all the data, and the measurement data was used Indicates that t test is applied, and χ is used for enumeration data 2 test.
[0027] result
[0028] The curative effect comparison between the two groups after treatment is shown in Table 1.
[0030] Comparison of the average value of white blood cells in the two groups before and after treatment. The average value of white blood cells in the two groups decreased after treatment, but the improvement in the treatment group was more significant than that in the control group (P<0.05). (See Table 2)


no PUM

Description & Claims & Application Information

We can also present the details of the Description, Claims and Application information to help users get a comprehensive understanding of the technical details of the patent, such as background art, summary of invention, brief description of drawings, description of embodiments, and other original content. On the other hand, users can also determine the specific scope of protection of the technology through the list of claims; as well as understand the changes in the life cycle of the technology with the presentation of the patent timeline. Login to view more.
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products